Science Explorer Back to mapMap
Discussion
Company · Leverkusen · Germany

ClinAssess (Germany)

clinassess.deROR OpenAlex
Research works
18
▲ 13% vs 2018-21
Citations
267
14.7 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
37%
world 40%
International
34%
world 18%
ClinAssess (Germany)

Not ranked overall: ClinAssess (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ClinAssess (Germany) work in?

In all years, 84% of research at ClinAssess (Germany) is in Health Sciences, 11% in Life Sciences. Its largest fields are Medicine (84%), Biochemistry, Genetics and Molecular Biology (9%), Psychology (4%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 84.4% of its workMedicine: 15 fractional works · 83.5% of its workOncology: 6 fractional works · 34.6% of its workPulmonary and Respiratory Medicine: 3 fractional works · 17.2% of its workPsychiatry and Mental health: 1 fractional works · 7.4% of its workHepatology: 1 fractional works · 2.9% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.7% of its workPathology and Forensic Medicine: 0 fractional works · 2.5% of its workSurgery: 0 fractional works · 2.4% of its workGastroenterology: 0 fractional works · 2.1% of its workNephrology: 0 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.9% of its workRheumatology: 0 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.8% of its workHematology: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.6% of its workPharmacy: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workLife Sciences: 2 fractional works · 11.0% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 9.2% of its workCancer Research: 1 fractional works · 6.3% of its workMolecular Biology: 0 fractional works · 2.1% of its workBiotechnology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 4.4% of its workPsychology: 1 fractional works · 4.1% of its workClinical Psychology: 0 fractional works · 1.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.8% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workPhysical Sciences: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workALL ITS WORKClinAssess(Germany)18fractional works, all years
Life Sciences11%Physical Sciences0%Health Sciences84%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine1583.5%
    2. Health Professions00.6%
    3. Nursing00.2%
    1. Biochemistry, Genetics and Molecular Biology29.2%
    2. Neuroscience01.0%
    3. Immunology and Microbiology00.5%
    4. Agricultural and Biological Sciences00.3%
    1. Psychology14.1%
    2. Economics, Econometrics and Finance00.4%
    1. Physics and Astronomy00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at ClinAssess (Germany)?

Ranked on the quality score, Swantje Held and Andreas Bachinger lead among researchers whose main affiliation is ClinAssess (Germany).

  1. 1 Swantje Held Germany · #847,900 worldwide 2.9k citations · 182 works
  2. 2 Andreas Bachinger Germany · #2,284,993 worldwide 342 citations · 18 works
All ranked researchers at ClinAssess (Germany)

What are the most cited papers from ClinAssess (Germany)?

The most cited paper from ClinAssess (Germany) is "FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial" (Sebastian Stintzing et al., 2016), with 424 citations. Next come "Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial" (207) and "Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial" (198).

Most cited papers
#PaperReleasedCitations
1 FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial Sebastian Stintzing et al. · The Lancet Oncology 2 Sep 2016 424
2 Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial Volker Kunzmann et al. · ˜The œLancet. Gastroenterology & hepatology 17 Dec 2020 207
3 Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial Sebastian Stintzing et al. · Annals of Oncology Open access Nov 2019 198
4 FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109) Dominik Paul Modest, Uwe M. Martens, Jorge Riera‐Knorrenschild et al. · Journal of Clinical Oncology 14 Oct 2019 198
5 FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas W. Decker et al. · British Journal of Cancer Open access 6 Nov 2020 194
All 60 most cited papers, with filters and sorting

Which research topics does ClinAssess (Germany) publish most on?

By volume in 2022-now: Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Renal function and acid-base balance and Sleep and related disorders.

Colorectal Cancer Treatm…1Colorectal Cancer Treatments and Studies: 1 fractional worksCancer Genomics and Diagnostics: 0 fractional worksRenal function and acid-base balance: 0 fractional worksSleep and related disord…0Sleep and related disorders: 0 fractional worksGastroesophageal reflux and treatments: 0 fractional worksPancreatic and Hepatic Oncology Research: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksGastric Cancer Management and Outcomes: 0 fractional worksGenetic factors in colorectal cancer: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional works
OncologyCancer ResearchNephrologyExperimental and Cognitive Psychology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Colorectal Cancer Treatments and Studies Oncology 1 works
  2. 2 Cancer Genomics and Diagnostics Cancer Research 0 works
  3. 3 Renal function and acid-base balance Nephrology 0 works
  4. 4 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  5. 5 Gastroesophageal reflux and treatments Gastroenterology 0 works
  6. 6 Pancreatic and Hepatic Oncology Research Oncology 0 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  8. 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  9. 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  10. 10 Cancer Treatment and Pharmacology Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 40% of research is openly available.

with international co-authors34.5%domestic only65.5%

World: 18% is written across borders.

How has ClinAssess (Germany)'s research output changed?

Output in 2022-2025 was 13% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ClinAssess (Germany) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.000050%0.00010%ClinAssess (Germany)0.000014% in 202520102020

Fractional works of ClinAssess (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Leverkusen

All research institutions in Leverkusen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ClinAssess (Germany). Posts are plain text and can be reported.